Dheeraj Kumar Lohia decreased his stake in Kwality Pharmaceuticals from 1.86% to 1.66%, selling 20,904 shares.
A pharmaceutical manufacturer and trader engaged in producing and distributing medicines and allied healthcare products across India. Established in 1983, the company operates in the competitive generics and branded pharmaceuticals segment, serving hospitals, clinics, and retail distribution channels nationwide. Its operations encompass formulation development, manufacturing, quality control, and distribution of pharmaceutical preparations across various therapeutic categories and medical specialties.
Known in small-cap circles for buying Shivalik Bimetals around ₹30 and holding through a 20x move, the kind of call that builds a reputation. Dheeraj Kumar Lohia operates through Dheeraj Kumar Lohia and Associates, running a ~₹228 Cr portfolio across 60+ stocks in industrials, pharma, and specialty niches. An early mover who consistently shows up in filings before the crowd arrives.
